✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals
Market Cap
₹70 Cr.
P/E
11.40
  • Godavari Drugs
  • Vivo Bio Tech
  • JFL Life Sciences
FAQs on Godavari Drugs Ltd. Shareprice

Godavari Drugs has given lower returns compared to its competitors.
Godavari Drugs has grown at ~9.83% over the last 2yrs while peers have grown at a median rate of 13.0%

Godavari Drugs is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE.
Latest PE of Godavari Drugs is 11.4, while 3 year average PE is 13.33.
Also latest EV/EBITDA of Godavari Drugs is 9.54 while 3yr average is 8.48.

Growth Table
  • Godavari Drugs Ltd.
  • Vivo Bio Tech
  • JFL Life Sciences
Balance Sheet
  • Godavari Drugs Ltd.
  • Vivo Bio Tech
  • JFL Life Sciences
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Godavari Drugs Ltd.
  • Vivo Bio Tech
  • JFL Life Sciences
Cash Flow
  • Godavari Drugs Ltd.
  • Vivo Bio Tech
  • JFL Life Sciences
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Godavari Drugs Ltd.
  • Vivo Bio Tech
  • JFL Life Sciences
Quarterly Results
  • Godavari Drugs Ltd.
  • Vivo Bio Tech
  • JFL Life Sciences
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
FAQs on Godavari Drugs Ltd. Financials

Balance sheet of Godavari Drugs is moderately strong, But short term working capital might become an issue for this company.

Yes, The debt of Godavari Drugs is increasing.
Latest debt of Godavari Drugs is ₹55.85 Crs as of Sep-24.
This is greater than Mar-24 when it was ₹52.52 Crs.

Yes, profit is increasing.
The profit of Godavari Drugs is ₹6.15 Crs for TTM, ₹5.55 Crs for Mar 2024 and ₹3.79 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Godavari Drugs latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Capital Work in Progress

Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech